MYC network mutations in high-risk chronic lymphocytic leukaemia
Sara Monti
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Search for more papers by this authorClara Deambrogi
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Search for more papers by this authorAndrea Rinaldi
Lymphoma and Genomics Research Program, IOR Institute of Oncology Research, Bellinzona, Switzerland
Search for more papers by this authorFrancesco Bertoni
Lymphoma and Genomics Research Program, IOR Institute of Oncology Research, Bellinzona, Switzerland
Lymphoma Unit, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Search for more papers by this authorGianluca Gaidano
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Search for more papers by this authorCorresponding Author
Davide Rossi
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
E-mail: [email protected]
Search for more papers by this authorSara Monti
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Search for more papers by this authorClara Deambrogi
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Search for more papers by this authorAndrea Rinaldi
Lymphoma and Genomics Research Program, IOR Institute of Oncology Research, Bellinzona, Switzerland
Search for more papers by this authorFrancesco Bertoni
Lymphoma and Genomics Research Program, IOR Institute of Oncology Research, Bellinzona, Switzerland
Lymphoma Unit, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Search for more papers by this authorGianluca Gaidano
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Search for more papers by this authorCorresponding Author
Davide Rossi
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
E-mail: [email protected]
Search for more papers by this author
References
- 1 Zhang W, Kater AP, Widhopf GF 2nd, et al. B-cell activating factor and v-MYC myelocytomatosis viral oncogene homolog (c-MYC) influence progression of chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2010; 107: 18956–18960.
- 2 Rossi D, Spina V, Deambrogi C, et al. The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. Blood 2011; 117: 3391–3401.
- 3 Cesarman E, Dalla-Favera R, Bentley D, Groudine M. Mutations in the first exon are associated with altered transcription of c-MYC in Burkitt lymphoma. Science 1987; 238: 1272–1275.
- 4 Dang CV. MYC on the path to cancer. Cell 2012; 149: 22–35.
- 5 Edelmann J, Holzmann K, Miller F, et al. High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations. Blood 2012; 120: 4783–4794.
- 6 De Paoli L, Cerri M, Monti S, et al. MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia. Leuk Lymphoma 2013; 54: 1087–1090.
- 7 Dühren-von Minden M, Übelhart R, Schneider D, et al. Chronic lymphocytic leukaemias driven by antigen-independent cell-autonomous signalling. Nature 2012; 489: 309–312.
- 8 Love C, Sun Z, Jima D, et al. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet 2012; 44: 1321–1325.
- 9 Richter J, Schlesner M, Hoffmann S, et al. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet 2012; 44: 1316–1320.
- 10 Schmitz R, Young RM, Ceribelli M, et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 2012; 490: 116–120.
- 11 Rossi D, Rasi S, Spina V, et al. Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia. Blood 2013; 121: 1403–1412.
- 12 Pasqualucci L, Neumeister P, Goossens T, et al. Hypermutationof multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001; 412: 341–346.
Citing Literature
